Envestnet Asset Management Inc Veracyte, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 76,192 shares of VCYT stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,192

Previous 120,007 36.51%

Holding current value

$3.34 Million

Previous $2.6 Million 0.31%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$21.0 - $35.25 $920,115 - $1.54 Million	-43,815 Reduced 36.51%	76,192 $2.59 Million
Q2 2024 Aug 08, 2024	SELL	$18.86 - $23.55 $270,414 - $337,659	-14,338 Reduced 10.67%	120,007 $2.6 Million
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $352,254 - $488,123	16,774 Added 14.27%	134,345 $2.98 Million
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $197,673 - $287,488	-10,024 Reduced 7.86%	117,571 $3.23 Million
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $993,260 - $1.33 Million	-44,481 Reduced 25.85%	127,595 $2.85 Million
Q2 2023 Aug 04, 2023	SELL	$20.96 - $26.99 $10.4 Million - $13.4 Million	-497,672 Reduced 74.31%	172,076 $4.38 Million
Q1 2023 May 11, 2023	BUY	$20.58 - $27.89 $10.9 Million - $14.8 Million	530,310 Added 380.32%	669,748 $14.9 Million
Q4 2022 Feb 07, 2023	BUY	$15.31 - $29.94 $152,273 - $297,783	9,946 Added 7.68%	139,438 $3.31 Million
Q3 2022 Nov 10, 2022	BUY	$16.58 - $27.9 $898,834 - $1.51 Million	54,212 Added 72.01%	129,492 $2.15 Million
Q2 2022 Aug 03, 2022	BUY	$15.45 - $29.52 $241,792 - $461,988	15,650 Added 26.25%	75,280 $1.5 Million
Q1 2022 May 04, 2022	BUY	$21.94 - $42.51 $251,366 - $487,037	11,457 Added 23.78%	59,630 $1.64 Million
Q4 2021 Feb 04, 2022	BUY	$36.09 - $53.79 $292,365 - $435,752	8,101 Added 20.22%	48,173 $1.99 Million
Q3 2021 Oct 07, 2021	BUY	$35.62 - $52.97 $61,017 - $90,737	1,713 Added 4.47%	40,072 $1.86 Million
Q2 2021 Aug 04, 2021	BUY	$32.94 - $56.62 $164,831 - $283,326	5,004 Added 15.0%	38,359 $1.53 Million
Q1 2021 May 04, 2021	BUY	$44.47 - $81.38 $302,618 - $553,790	6,805 Added 25.63%	33,355 $1.79 Million
Q4 2020 Feb 02, 2021	BUY	$32.49 - $61.88 $55,525 - $105,752	1,709 Added 6.88%	26,550 $1.3 Million
Q3 2020 Oct 09, 2020	SELL	$26.73 - $35.67 $31,835 - $42,482	-1,191 Reduced 4.58%	24,841 $807,000
Q2 2020 Jul 08, 2020	SELL	$19.49 - $28.11 $86,457 - $124,695	-4,436 Reduced 14.56%	26,032 $674,000
Q1 2020 Apr 23, 2020	BUY	$16.13 - $30.17 $15,855 - $29,657	983 Added 3.33%	30,468 $741,000
Q4 2019 Feb 11, 2020	BUY	$20.78 - $29.99 $139,371 - $201,142	6,707 Added 29.45%	29,485 $823,000
Q3 2019 Oct 17, 2019	BUY	$23.87 - $30.93 $9,333 - $12,093	391 Added 1.75%	22,778 $547,000
Q2 2019 Aug 02, 2019	BUY	$22.1 - $28.56 $494,752 - $639,372	22,387 New	22,387 $638,000

Others Institutions Holding VCYT

# of Institutions

311

Shares Held

82M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Veracyte, Inc. Transaction History